Biocon Archives - Express Pharma

Biocon’s S&P Global ESG Score improves to 69 for 2024

Innovation, partnerships and best practices: Priorities for biopharma in 2025

Biocon receives EIR with VAI status

17th CPHI & PMEC India Expo to highlight advancements in pharma industry

Biocon and Dr Reddy’s featured in Science Magazine’s Top Employers List

Biocon signs licensing agreement with Tabuk Pharmaceuticals for GLP-1 products

Budget 2024-25 prioritises R&D, education and business for MSMEs

Biocon appoints Mukesh Kamnath as interim CFO

Biocon partners with Handok to commercialise Liraglutide in South Korea

Biocon signs deal with Medix to market generic Saxenda in Mexico